Inner-City Asthma Consortium

Clinical Studies

NIAID supports research to address the disproportionate public health burden of asthma in inner-city populations. NIAID funds the Inner-City Asthma Consortium (ICAC), whose research focuses on understanding how the environment, allergens, and genetics interact with the body’s immune system to cause asthma and aggravate its symptoms.

The following ICAC clinical study is recruiting participants. The link leads to full eligibility criteria, study site locations, and contact information:

Registry for Asthma Characterization and Recruitment 2 (RACR2) (NCT02513264)
There is a need for people to take part in research studies to learn more about diseases and how to treat them. RACR2 will create a database of participants ages 1-55 years with asthma and nasal allergies, or risk factors for these conditions, who are potentially eligible for future ICAC trials.

Read more about the NIAID role in asthma research.

Visit the NIH website to learn about the importance of children in clinical studies.

Content last reviewed on May 16, 2017